Form 4 for PRTA PROTHENA CORP PUBLIC LTD CO
Accepted 2022-07-08 00:00:00 ET · period of report 2022-07-06 · accession 0001567619-22-013840 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-08 | 2022-07-06 | PRTA | Garren Hideki | Chief Medical Off | S - Sale+OE | $30.00 | -8,000 | 0 | -100% | -$240.0K |
| D | 2022-07-08 | 2022-07-06 | PRTA | Garren Hideki | Chief Medical Off | M - OptEx | $24.90 | +8,000 | 8,000 | New | +$199.2K |
| D | 2022-07-08 | 2022-07-06 | PRTA | Garren Hideki | Chief Medical Off | M - OptEx | $0.00 | -8,000 | 242.0K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value $0.01 per share | 2022-07-06 | S | D | 8,000 | $30.00 | 0 | D | — | — | |
| 2 | Common | Ordinary Shares, par value $0.01 per share | 2022-07-06 | M | A | 8,000 | $24.90 | 8,000 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-07-06 | M | D | 8,000 | $0.00 | 242,000 | D | $24.90 · — to 2031-04-05 | 8,000 Ordinary Shares | (F2) The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on April 5, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. |